Turk Ilac Ve Serum Sanayi Anonim Sirketi (IST:TRILC)
24.98
+0.76 (3.14%)
Feb 28, 2025, 10:00 AM GMT+3
IST:TRILC Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Revenue | 1,682 | 1,913 | 1,637 | 672.6 | 199.5 | 152.12 | Upgrade
|
Revenue Growth (YoY) | -41.88% | 16.88% | 143.37% | 237.14% | 31.15% | 56.35% | Upgrade
|
Cost of Revenue | 1,053 | 1,487 | 1,288 | 556.27 | 101 | 83.64 | Upgrade
|
Gross Profit | 628.86 | 426.62 | 348.83 | 116.33 | 98.5 | 68.48 | Upgrade
|
Selling, General & Admin | 175.97 | 158.99 | 171.35 | 40.3 | 26.54 | 21.36 | Upgrade
|
Other Operating Expenses | -0.5 | -3.02 | 80.4 | 2.96 | 1.79 | 1.97 | Upgrade
|
Operating Expenses | 175.46 | 155.97 | 251.75 | 43.26 | 28.33 | 23.33 | Upgrade
|
Operating Income | 453.39 | 270.65 | 97.08 | 73.08 | 70.17 | 45.15 | Upgrade
|
Interest Expense | -368.83 | -171.99 | -155.96 | -32.09 | -41.86 | -36.71 | Upgrade
|
Interest & Investment Income | 29.64 | 20.78 | 35.19 | 4.86 | 16.24 | 9.97 | Upgrade
|
Currency Exchange Gain (Loss) | -5.44 | -12.07 | 3.88 | 1.96 | -4.61 | -1.01 | Upgrade
|
Other Non Operating Income (Expenses) | 83.94 | -23.31 | -62.9 | -0.81 | -0.11 | -0.49 | Upgrade
|
EBT Excluding Unusual Items | 192.71 | 84.07 | -82.7 | 47 | 39.83 | 16.91 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.31 | -1.99 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | 0.56 | 0.71 | Upgrade
|
Legal Settlements | -2.84 | - | -0.07 | -0.14 | -0.13 | -0.13 | Upgrade
|
Pretax Income | 190.22 | 82.12 | -9.67 | 46.86 | 40.26 | 17.49 | Upgrade
|
Income Tax Expense | -66.15 | -23.6 | 71.99 | 9.72 | 6.93 | 4.01 | Upgrade
|
Net Income | 256.36 | 105.72 | -81.65 | 37.14 | 33.33 | 13.48 | Upgrade
|
Net Income to Common | 256.36 | 105.72 | -81.65 | 37.14 | 33.33 | 13.48 | Upgrade
|
Net Income Growth | - | - | - | 11.42% | 147.22% | -6.33% | Upgrade
|
Shares Outstanding (Basic) | 161 | 162 | 162 | 162 | 141 | 141 | Upgrade
|
Shares Outstanding (Diluted) | 161 | 162 | 162 | 162 | 141 | 141 | Upgrade
|
Shares Change (YoY) | -1.47% | - | - | 15.00% | - | 168.00% | Upgrade
|
EPS (Basic) | 1.60 | 0.65 | -0.50 | 0.23 | 0.24 | 0.10 | Upgrade
|
EPS (Diluted) | 1.60 | 0.65 | -0.50 | 0.23 | 0.24 | 0.10 | Upgrade
|
EPS Growth | - | - | - | -3.11% | 147.22% | -65.05% | Upgrade
|
Free Cash Flow | -727.98 | 201.82 | 109.51 | -92.27 | 16.66 | -11.6 | Upgrade
|
Free Cash Flow Per Share | -4.53 | 1.25 | 0.68 | -0.57 | 0.12 | -0.08 | Upgrade
|
Gross Margin | 37.39% | 22.30% | 21.31% | 17.30% | 49.38% | 45.02% | Upgrade
|
Operating Margin | 26.96% | 14.15% | 5.93% | 10.86% | 35.17% | 29.68% | Upgrade
|
Profit Margin | 15.24% | 5.53% | -4.99% | 5.52% | 16.71% | 8.86% | Upgrade
|
Free Cash Flow Margin | -43.29% | 10.55% | 6.69% | -13.72% | 8.35% | -7.62% | Upgrade
|
EBITDA | 474.28 | 298.24 | 110.85 | 80.61 | 76.49 | 49.95 | Upgrade
|
EBITDA Margin | 28.20% | 15.59% | 6.77% | 11.98% | 38.34% | 32.83% | Upgrade
|
D&A For EBITDA | 20.89 | 27.58 | 13.77 | 7.53 | 6.32 | 4.79 | Upgrade
|
EBIT | 453.39 | 270.65 | 97.08 | 73.08 | 70.17 | 45.15 | Upgrade
|
EBIT Margin | 26.96% | 14.15% | 5.93% | 10.86% | 35.17% | 29.68% | Upgrade
|
Effective Tax Rate | - | - | - | 20.74% | 17.21% | 22.91% | Upgrade
|
Advertising Expenses | - | 0.12 | 1.47 | 0.14 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.